BlackRock Health Sciences Opportunities Portfolio is a registered fund series of BlackRock Funds (series S000001877). Net assets $5.9B as of 2026-05-29.
Showing 15 of 155 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| ELI LILLY & COMPANY | LLY | $725.6M | 1228.60% |
| JOHNSON & JOHNSON | JNJ | $518.1M | 877.23% |
| UNITEDHEALTH GROUP INC | UNH | $360.3M | 610.09% |
| MERCK & COMPANY INC | MRK | $291.6M | 493.80% |
| GILEAD SCIENCES INC | GILD | $247.5M | 419.12% |
| ABBVIE INC | ABBV | $232.5M | 393.72% |
| AMGEN INC | AMGN | $198.8M | 336.57% |
| THERMO FISHER SCIENTIFIC INC | TMO | $178.5M | 302.16% |
| VERTEX PHARMACEUTICALS INC | VRTX | $162.0M | 274.25% |
| PFIZER INC | PFE | $154.4M | 261.49% |
| EDWARDS LIFESCIENCES CORP | EW | $147.9M | 250.51% |
| DANAHER CORP | DHR | $117.8M | 199.54% |
| ABBOTT LABORATORIES | ABT | $116.6M | 197.39% |
| INTUITIVE SURGICAL INC | ISRG | $115.3M | 195.16% |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | $110.2M | 186.67% |
| Report date | Net assets |
|---|---|
| 2026-05-29 | $5.9B |
| 2026-02-27 | $6.5B |
| 2025-11-28 | $6.8B |
| 2025-08-29 | $6.2B |
| 2025-05-30 | $6.5B |
| 2025-02-28 | $7.5B |
| 2024-11-29 | $8.0B |
| 2024-08-30 | $8.7B |